Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

10 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Association of creatine kinase and skin toxicity in phase I trials of anticancer agents.
Moreno Garcia V, Thavasu P, Blanco Codesido M, Molife LR, Vitfell Pedersen J, Puglisi M, Basu B, Shah K, Iqbal J, de Bono JS, Kaye SB, Banerji U. Moreno Garcia V, et al. Among authors: blanco codesido m. Br J Cancer. 2012 Nov 20;107(11):1797-800. doi: 10.1038/bjc.2012.482. Epub 2012 Oct 25. Br J Cancer. 2012. PMID: 23099802 Free PMC article.
Cancer therapeutics: Targeting the apoptotic pathway.
Khan KH, Blanco-Codesido M, Molife LR. Khan KH, et al. Among authors: blanco codesido m. Crit Rev Oncol Hematol. 2014 Jun;90(3):200-19. doi: 10.1016/j.critrevonc.2013.12.012. Epub 2013 Dec 18. Crit Rev Oncol Hematol. 2014. PMID: 24507955 Review.
A phase I, dose-escalation study of the multitargeted receptor tyrosine kinase inhibitor, golvatinib, in patients with advanced solid tumors.
Molife LR, Dean EJ, Blanco-Codesido M, Krebs MG, Brunetto AT, Greystoke AP, Daniele G, Lee L, Kuznetsov G, Myint KT, Wood K, de Las Heras B, Ranson MR. Molife LR, et al. Among authors: blanco codesido m. Clin Cancer Res. 2014 Dec 15;20(24):6284-94. doi: 10.1158/1078-0432.CCR-14-0409. Epub 2014 Oct 2. Clin Cancer Res. 2014. PMID: 25278451 Clinical Trial.
Prognostic value of carcinoembryonic antigen level in rectal cancer treated with neoadjuvant chemoradiotherapy.
Moreno García V, Cejas P, Blanco Codesido M, Feliu Batlle J, de Castro Carpeño J, Belda-Iniesta C, Barriuso J, Sánchez JJ, Larrauri J, González-Barón M, Casado E. Moreno García V, et al. Among authors: blanco codesido m. Int J Colorectal Dis. 2009 Jul;24(7):741-8. doi: 10.1007/s00384-009-0682-6. Epub 2009 Mar 4. Int J Colorectal Dis. 2009. PMID: 19259690
Prognostic value of molecular biomarkers in patients with metastatic colorectal cancer: a real-world study.
García-Alfonso P, García-González G, Gallego I, Peligros MI, Ortega L, Torres Pérez-Solero G, Sandoval C, Muñoz Martin A, Blanco Codesido M, Calvo Ferrándiz A, Martin M. García-Alfonso P, et al. Among authors: blanco codesido m. Clin Transl Oncol. 2021 Jan;23(1):122-129. doi: 10.1007/s12094-020-02402-x. Epub 2020 Jun 9. Clin Transl Oncol. 2021. PMID: 32519179
Incidence of venous thromboembolism (VTE) in ambulatory pancreatic cancer patients receiving chemotherapy and analysis of Khorana's predictive model.
Muñoz Martín AJ, García Alfonso P, Rupérez Blanco AB, Pérez Ramírez S, Blanco Codesido M, Martín Jiménez M. Muñoz Martín AJ, et al. Among authors: blanco codesido m. Clin Transl Oncol. 2014 Oct;16(10):927-30. doi: 10.1007/s12094-014-1165-y. Epub 2014 Mar 19. Clin Transl Oncol. 2014. PMID: 24643701
Oral drugs in the treatment of metastatic colorectal cancer.
García-Alfonso P, Muñoz Martín AJ, Ortega Morán L, Soto Alsar J, Torres Pérez-Solero G, Blanco Codesido M, Calvo Ferrandiz PA, Grasso Cicala S. García-Alfonso P, et al. Among authors: blanco codesido m. Ther Adv Med Oncol. 2021 Apr 29;13:17588359211009001. doi: 10.1177/17588359211009001. eCollection 2021. Ther Adv Med Oncol. 2021. PMID: 33995592 Free PMC article. Review.